Veradigm (NASDAQ:MDRX) Shares Gap Down - Time to Sell?

Key Points

• Gapped down at the open to $4.15 from a prior close of $4.65 (the report notes the stock was down about 6.5%), though it was last quoted around $4.64 with light volume (~4,700 shares).
• Analyst action: Wall Street Zen recently upgraded Veradigm to a "hold."
• The company has a market cap of $473.72 million, a P/E of 23.25 and a low beta (0.54), trading near its 50-day and 200-day SMAs of about $4.62 and $4.72 respectively.

Veradigm Inc. (NASDAQ:MDRX - Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $4.65, but opened at $4.15. Veradigm shares last traded at $4.64, with a volume of 4,697 shares.

Analysts Set New Price Targets

Separately, Wall Street Zen upgraded Veradigm to a "hold" rating in a report on Saturday.

Veradigm Stock Down 6.5%

The company has a market cap of $473.72 million, a price-to-earnings ratio of 23.25 and a beta of 0.54. The stock's 50-day simple moving average is $4.62 and its 200 day simple moving average is $4.72.

About Veradigm

Veradigm, Inc NASDAQ: MDRX is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company's offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm's product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.